Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

Cyclophosphamide 19 fludarabine 18 Tacrolimus 10 Whole-Body Irradiation 9 Mycophenolic Acid 8 venetoclax 7 fludarabine phosphate 7 Sirolimus 7 Azacitidine 7 Mesna 5 Dexamethasone 5 Bortezomib 5 Rituximab 4 Methotrexate 4 Busulfan 4 daratumumab 3 Stem Cell Transplantation 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Melphalan 3 Lenalidomide 3 Filgrastim 3 Cytarabine 3 Biopsy 3 Alemtuzumab 3 AP 1903 reagent 3 pomalidomide 2 merphos 2 isatuximab 2 ibrutinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hematologic Neoplasms × Methoxsalen × Clear all

NCT00930566 2013-04-24

ECP

Hospices Civils de Lyon

Phase 1/2 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡